Nelson Bernardo, MD
Interventional Cardiology · Washington, DCNPI 1255373692
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 41 manufacturers reported payments, led by Cook Incorporated at 49.9% of the total. Reporting peaked in 2019 at $28,262 and has fallen 89.4% since, to $2,997 in 2025.
Across 745 payments — averaging $73.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$27K
- Cook Medical LLC$7K
- Endologix LLC$3K
- Medtronic$2K
- W. L. Gore & Associates, Inc.$2K
- Boston Scientific$2K
- plus $12K from 35 others
Across 334 payments — averaging $3503.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$399K
- Shockwave Medical, Inc$272K
- Boston Scientific$215K
- Surmodics, Inc.$64K
- Endologix LLC$46K
- Contego Medical, Inc$43K
- plus $132K from 9 others
What the payments were for
- Consulting fees$1,2002%
- Speaking & faculty fees$27,16049%
- Travel & lodging$5,49810%
- Food & beverage$21,00938%
- Education$1380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 7 | $27,456 |
| Cook Medical LLC | 87 | $6,919 |
| Endologix LLC | 15 | $2,964 |
| Medtronic(2 entities) | 77 | $2,468 |
| W. L. Gore & Associates, Inc. | 35 | $1,599 |
| Boston Scientific | 69 | $1,551 |
| Cardiovascular Systems Inc. | 69 | $1,418 |
| Shockwave Medical, Inc | 36 | $1,043 |
| Abbott | 52 | $1,027 |
| Amgen | 32 | $912 |
| Cordis US CORP. | 14 | $778 |
| AstraZeneca | 38 | $777 |
| Terumo Medical Corporation | 15 | $548 |
| Penumbra, Inc. | 7 | $547 |
| Inari Medical, Inc. | 10 | $481 |
| Abiomed | 22 | $439 |
| Johnson & Johnson | 26 | $437 |
| Novo Nordisk | 15 | $361 |
| Philips North America LLC | 9 | $347 |
| Pfizer | 17 | $330 |
| Chiesi USA, Inc. | 15 | $329 |
| Cardinal Health 200 LLC | 8 | $329 |
| Teleflex LLC | 6 | $263 |
| Silk Road Medical, Inc. | 8 | $229 |
| E.r. Squibb & Sons, L.L.C. | 11 | $229 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $196 |
| Recor Medical Inc | 9 | $170 |
| Corindus Inc. | 1 | $115 |
| Angiodynamics, Inc. | 1 | $103 |
| Novartis | 4 | $97 |
| Biotronik Inc. | 2 | $94 |
| Bard Peripheral Vascular, Inc. | 2 | $79 |
| Edwards Lifesciences | 1 | $71 |
| Cardiva Medical, Inc. | 3 | $52 |
| Stryker | 1 | $50 |
| Boehringer Ingelheim | 2 | $47 |
| Mimedx Group, Inc. | 1 | $46 |
| Smith+Nephew | 2 | $36 |
| Asahi Intecc USA, Inc. | 1 | $29 |
| Atricure, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cook Medical Filters$9,187
- Zilver PTX$7,560
- Cook Medical IAA$5,496
- Cook Medical Micropuncture$5,200
- ENDOCROSS Device$1,580
- Torus Stent Graft System$1,580
- GORE CARDIOFORM Septal Occluder$282
- GORE VIABAHN VBX Balloon Expandable Endo$262
- RESOLUTE ONYX$255
- CARDIOFORM Septal Occluder$245
- Cook Medical Peripheral Intervention$245
- Cook Medical Zilver PTX$241
- Micropuncture$222
- Diamondback Peripheral$169
- WATCHMAN Access System$165
- PERFORMER$161
- TURNPIKE$159
- ROTAPRO$150
- Impella$146
- KENGREAL$130
How this compares
Too few interventional cardiology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 26 | $24,197 |
| BrilintaTicagrelor | 16 | $14,573 |
| ClopidogrelClopidogrel Bisulfate | 75 | $1,045 |
| Carvedilol | 16 | $470 |
| Pantoprazole Sodium | 14 | $175 |
| Atorvastatin Calcium | 18 | $167 |
| Losartan Potassium | 15 | $151 |
| Metoprolol Succinate | 13 | $142 |
| Prednisone | 13 | $54 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $330 | $24,19726 claims |
| AstraZenecaBrilinta | $777 | $14,57316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few interventional cardiology providers in District of Columbiaon file to place this against a meaningful peer group, so we don't.
Other interventional cardiology in Washington
- Ron WaksmanWashington$915K
- Toby RogersWashington$880K
- Augusto PichardWashington$180K
- Lowell SatlerWashington$112K
- Jonathan ReinerWashington$77K
- Brian CaseWashington$63K
- Horst SievertWashington$58K
- Ramesh MazhariWashington$41K
- Itshac Ben-DorWashington$25K
- Nardos TemesgenWashington$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.